Posted by & filed under Company Analysis, Financial analysis, Financial Planning, Growth & Valuation.

Description: Valeant Pharmaceuticals scored a knockout punch Monday in the bidding war for Salix Pharmaceuticals Ltd., even though a frenetic M&A race in the pharmaceutical industry forced it to pay more than it originally hoped.


Date: March 16, 2015


Questions for discussion:

  • Why are pharma mergers and acquisitions like this one taking place, according to the report?
  • Do you think it is a good deal for both companies?

Leave a Reply

Your email address will not be published. Required fields are marked *